Share this article
Company Continues to Improve Gross Cash Position to Execute Business Plan
TORONTO, March 8, 2021 /PRNewswire/ - SQI Diagnostics Inc. (the Company or SQI ) (TSXV: SQD) (OTCQB: SQIDF), a precision medicine company that discovers, develops, and commercializes innovative rapid diagnostic testing for healthcare professionals, patients and consumers worldwide, announces that 9,775,972 common share purchase warrants (the Warrants ) and 1,500,000 stock options (the Options ) have been exercised at exercise prices between $0.09 and $0.30 per common shares since January 1, 2021, resulting in gross proceeds of approximately $2.3 million to the Company (the Funding ). The Options were exercised by a director of the Company and the Warrants were exercised by non-insiders of the Company.
Toronto launches COVID-19 vaccine-booking website as provincial system is prepared
theglobeandmail.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theglobeandmail.com Daily Mail and Mail on Sunday newspapers.
This is truly a team Toronto effort : City to open 3 mass vaccination clinics on March 17
680news.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 680news.com Daily Mail and Mail on Sunday newspapers.